ABOUT THIS PROJECT
About Reviews DSIP
An instrument-panel reading of the published DSIP literature — leading with what was measured, and keeping the blank dials in plain view.
What this site is
Reviews DSIP is an instrument panel for the peer-reviewed research on DSIP, the delta sleep-inducing peptide: plain-English summaries laid out like readings on a panel, each dial labeled with the study it came from. It runs no clinic and employs no clinicians. It offers no medical advice. It makes, sells, and ships nothing. The writing is commentary on published science, and every figure is cited.
The name carries 'reviews' because appraisal is the posture this panel takes toward the literature: it weighs the studies, leads with what was actually measured, and is as careful to mark the blank dials — the undiscovered receptor, the missing modern trial, the un-validated human pharmacokinetics — as to report the findings. 'Reviews' describes how the science is read; it is not a claim to review, rank, or endorse any vendor or product, and it does not.
How we work
Every quantitative claim — every dose, percentage, half-life, and study result — maps to a numbered source on the DSIP references page, drawn from PubMed-indexed journals and reviews. Findings are described in the form 'studied at X in species Y,' never as a personal recommendation, and no human dosing protocol is ever published.
DSIP is treated exactly as the evidence warrants: a real, well-described endogenous peptide with a famous founding result, a handful of small old human studies, and a mechanism that, after more than forty years, remains genuinely unresolved. Where a 2006 review called the field a 'still unresolved riddle,' the panel quotes it rather than smoothing it over. The aim is a reading a curious non-scientist can trust precisely because it doesn't oversell.

What this site is not
This is not a store, a pharmacy, or a medical service. It sells no DSIP and no peptide, links to no vendor, and takes no position on where anyone obtains research materials. It offers no consultations, treatment, or prescriptions, and nothing here should be read as medical advice. DSIP is not approved as a medicine by any regulator, and the panel says so plainly throughout.
A persistent sleep problem is a matter for a qualified healthcare professional, not a research peptide — a point the DSIP effects page makes in detail. The role here begins and ends with reading the published science and reporting it honestly.